U.S.: Settlement Reached on Washington State Medicaid Denial of Pricey Hep C Drugs

The Health Care Authority on Monday reached a settlement agreement in a class action lawsuit that sought broader coverage of costly hepatitis C drugs for Medicaid patients in Washington state. The settlement has yet to be approved by a judge but lawyers are hopeful it will be soon. In the past several years, multiple pharmaceutical companies nationwide have developed direct-acting antiviral drugs that cure hepatitis C in more than 90 percent of patient